Delivery Order SPE2DB25D3108-SPE2DB26FPBLB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,956.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 25, 2025, with completion scheduled for August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,488.88 on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This firm fixed-price contract, with a completion date of October 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The delivery order was awarded non-competitively as a competitively...
- The Defense Logistics Agency awarded a delivery order valued at $13,633.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 24, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,847.16 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was...
- The Defense Logistics Agency (DLA) awarded a $1,744.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL quantity) on December 8, 2025, with completion targeted for December 9, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,358.85 for Trulicity 1.5 mg/0.5 mL pens on November 25, 2025, with completion scheduled for November 26, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a single pharmaceutical supply transaction to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,592.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,868.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $2,266.83, with completion scheduled for September 16, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The award was issued on September 15, 2025, with performance based in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price, competitively awarded contract carries an ultimate completion date of October 31, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child delivery order issued under a larger contract vehicle supporting the federal government's pharmaceutical...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB26FPBLBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,846.86 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml dosage) on October 27, 2025, with completion expected by October 28, 2025. This non-competitive, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to military and veteran healthcare systems through the DLA Medical Supply Chain. This specific delivery order for Trulicity, a diabetes medication, is consistent with the company's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The underlying SPE2DX contract serves as a flexible, global pharmaceutical support vehicle enabling AmerisourceBergen to deliver critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 10/27/25 |